(19)
(11) EP 4 816 000 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898832.1

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 48/00(2006.01)
A61P 7/04(2006.01)
C12N 15/113(2010.01)
A61K 31/7088(2006.01)
A61K 9/127(2025.01)
C07K 14/755(2006.01)
C12N 9/22(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 7/04; C07K 14/755; C12N 9/22; C12N 15/113; A61K 31/711; C12N 15/85; A61K 48/005; C12N 15/88; A61K 38/00; A61K 9/1271; A61K 9/5146; A61K 9/0019; C12N 2310/20; C12N 2310/315; C12N 2310/321; C12N 2310/322; C12N 2320/33
 
C-Sets:
  1. C12N 2310/321, C12N 2310/3521;
  2. C12N 2310/322, C12N 2310/3533;

(86) International application number:
PCT/US2024/057905
(87) International publication number:
WO 2025/117858 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603511 P
26.07.2024 US 202463676239 P
09.09.2024 US 202463692539 P
06.11.2024 US 202463717090 P

(71) Applicant: Metagenomi Therapeutics, Inc.
Emeryville, CA 94608 (US)

(72) Inventors:
  • THOMAS, Brian C.
    Emeryville, California 94608 (US)
  • AFRIKANOVA, Ivka
    Emeryville, California 94608 (US)
  • BROOKS, Alan
    Emeryville, California 94608 (US)
  • GAMBOA, Luis
    Emeryville, California 94608 (US)
  • HO, Samuel
    Emeryville, California 94608 (US)
  • MEI, Janet
    Emeryville, California 94608 (US)
  • STANTEN, Kalya
    Emeryville, California 94608 (US)
  • SZYMANSKI, Paul
    Emeryville, California 94608 (US)
  • TASSA, Carlos
    Emeryville, California 94608 (US)

(74) Representative: HGF 
HGF Limited 4th Floor, 1 City Square
Leeds LS1 2ES
Leeds LS1 2ES (GB)

   


(54) SUPPLEMENTATION OF LIVER ENZYME EXPRESSION